Skip to main content
. 2023 Aug 22;52(6):1716–1724. doi: 10.1093/ije/dyad114

Table 2.

Socio-demographic characteristics by primary outcome measure of COVID-19-associated mortality and all-cause mortality, with the time under risk in person-years for each event stratified by the vaccine dose

Third-dose recipients a
Fourth-dose recipients
Monovalent vaccine
BA.1 bivalent vaccine
BA.4–5 bivalent vaccine
Person-time b
COVID-19-associated mortality
All-cause mortality
Person-time b
COVID-19-associated mortality
All-cause mortality
Person-time b
COVID-19-associated mortality
All-cause mortality
Person-time b
COVID-19-associated mortality
All-cause mortality
Years % n % n % Years % n % n % Years % n % n % Years % n % n %
Sex
 Female 50 834 56.80% 194 47.90% 3503 53.10% 61 365 55.22% 154 49.52% 3678 57.17% 5314 53.44% 4 50.0% 115 48.12% 2522 54.07% 2 25.0% 82 51.25%
 Male 38 718 43.20% 211 52.10% 3095 46.90% 49 758 44.78% 157 50.48% 2755 42.83% 4630 46.56% 4 50.0% 124 51.88% 2143 45.93% 6 75.0% 78 48.75%
Age (years)
 75–79 43 998 49.10% 79 19.50% 1510 22.90% 51 701 46.53% 57 18.33% 1057 16.43% 5648 56.80% 2 25.0% 61 25.52% 2502 53.64% 4 50.0% 42 26.25%
 80–84 23 589 26.30% 70 17.30% 1446 21.90% 31 723 28.55% 58 18.65% 1346 20.92% 2444 24.57% 2 25.0% 41 17.15% 1169 25.07% 0 36 22.50%
 85–89 13 689 15.30% 102 25.20% 1605 24.30% 17 388 15.65% 82 26.37% 1651 25.66% 1230 12.37% 1 12.5% 73 30.54% 636 13.63% 2 25.0% 42 26.25%
 90+ 8275 9.20% 154 38.00% 2037 30.90% 10 311 9.28% 114 36.66% 2379 36.98% 623 6.26% 3 37.5% 64 27.00% 358 8.00% 2 25.0% 40 25.00%
Region
 Innlandet 8305 9.30% 33 8.10% 592 9.00% 9157 8.00% 31 9.97% 570 8.86% 1145 11.51% 3 37.5% 29 12.13% 409 8.76% 0 18 11.25%
 Trøndelag 8205 9.20% 27 6.70% 604 9.20% 10 046 9.04% 27 8.68% 596 9.26% 847 8.52% 1 12.5% 23 9.62% 281 6.01% 1 12.5% 10 6.25%
 Nord-Norge 10 978 12.30% 40 9.90% 739 11.20% 8403 7.56% 22 7.07% 514 7.99% 1000 10.06% 0 0.0% 16 6.69% 565 12.11% 0 16 10.00%
 Oslo & Viken 27 028 30.20% 132 32.60% 1948 29.50% 38 520 34.66% 109 35.05% 2155 33.50% 3004 30.21% 2 25.0% 68 28.45% 1924 41.25% 3 37.5% 54 33.75%
 Agder & Sørøstlandet 13 006 14.50% 46 11.40% 975 14.80% 16 673 15.00% 39 12.54% 975 15.16% 1473 14.81% 0 27 11.30% 739 15.85% 3 37.5% 39 24.38%
 Vestlandet 22 031 24.60% 127 31.40% 1740 26.40% 28 324 25.49% 83 26.69% 1623 25.23% 2475 24.89% 2 25.0% 76 31.80% 747 16.01% 1 12.5% 23 14.38%
Risk group
 None 42 089 47.00% 120 29.60% 1929 29.20% 51 804 46.62% 113 36.00% 2010 31.00% 4741 48.00% 3 37.5% 76 31.80% 2211 47.40% 2 25.0% 46 28.75%
 Medium 41 036 45.80% 220 54.30% 3622 54.90% 50 849 45.76% 165 53.05% 3555 55.26% 4505 45.31% 4 50.0% 126 52.72% 2120 45.45% 5 62.5% 91 56.88%
 High 6427 7.20% 65 16.00% 1047 15.90% 8469 7.62% 33 10.61% 868 13.49% 698 7.02% 1 12.5% 37 15.00% 334 7.00% 1 12.5% 23 14.00%
LTCF resident
 No 86 319 96.40% 277 68.40% 5096 77.20% 10 5061 94.55% 163 52.41% 3999 62.16% 9829 98.85% 8 100.0% 213 89.12% 4592 98.44% 8 100.0% 137 85.63%
 Yes 3233 3.60% 128 31.60% 1502 22.80% 6061 5.45% 148 47.59% 2434 37.84% 115 1.16% 0 26 10.88% 73 1.56% 0 23 14.38%

LTCF, long-term care facility; COVID-19, coronavirus disease 2019; n, number.

a

Individuals who received their third dose >24 weeks ago.

b

The time under risk for third- and fourth-dose recipients until censoring or occurrence of the respective event.